Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors
Open Access
- 1 October 2014
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 7 (5) , 525-536
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Longitudinal Bioluminescence Imaging of the Dynamics of Doxorubicin Induced ApoptosisTheranostics, 2013
- Enhanced Antitumor Efficacy and Reduced Systemic Toxicity of Sulfatide-Containing Nanoliposomal Doxorubicin in a Xenograft Model of Colorectal CancerPLOS ONE, 2012
- Design of polymeric nanoparticles for biomedical delivery applicationsChemical Society Reviews, 2012
- Surface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticlesInternational Journal of Nanomedicine, 2012
- Antitumor and Immunopotentiating Activity of Polysaccharide PST001 Isolated from the Seed Kernel ofTamarindus indica: An In Vivo Study in MiceThe Scientific World Journal, 2012
- Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination TherapyMolecular Pharmaceutics, 2011
- Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicinesAdvanced Drug Delivery Reviews, 2009
- Biofunctionalized targeted nanoparticles for therapeutic applicationsExpert Opinion on Biological Therapy, 2008
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- Immunomodulatory effects of a polysaccharide from Tamarindus indicaAnti-Cancer Drugs, 1993